TERN — Terns Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $332.31m
- $68.87m
- 34
- 30
- 28
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -68.8 | -40.6 | -50.2 | -60.3 | -90.2 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.628 | 4.62 | 9.03 | 11.4 | 21.1 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.77 | 5.06 | -1.43 | -1.04 | 1.29 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -66.2 | -29.8 | -41.8 | -49.1 | -67.4 |
Capital Expenditures | -0.9 | -0.584 | -0.34 | -0.275 | -0.052 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2.96 | 7.28 | -119 | -22 | -37.9 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -3.86 | 6.69 | -120 | -22.3 | -38 |
Financing Cash Flow Items | 0.036 | -0.858 | -2.72 | -0.401 | -0.344 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.062 | 85.5 | 134 | 167 | 42 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -70.1 | 62.5 | -27.2 | 95.5 | -63.3 |